We are live on
!
Find out more
NI
Natural Investments Portfolio holdings
AUM
$455M
1-Year Est. Return
27.07%
This Fund
S&P 500
1 Year Est. Return
+27.07%
AUM
$455M
AUM Growth
+$49.8M
(+12%)
Holding
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 | +$2.51M | |
| 2 | +$1.7M | |
| 3 | +$1.42M | |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26M |
| 5 |
Advanced Micro Devices
AMD
|
+$1.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 | +$3.87M | |
| 2 | +$3.86M | |
| 3 | +$1.73M | |
| 4 |
Sony
SONY
|
+$1.71M |
| 5 |
Shinhan Financial Group
SHG
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.63% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 9.51% |
| 4 | Industrials | 6.52% |
| 5 | Communication Services | 4.79% |
Similar funds
EGP
BRF
OCM
AA
HIM
PC
FCMV
PC
Natural Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Natural Investments held 320 positions worth $455M, up 12% from $405M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Natural Investments's Q2 2026 filing shows 32 new, 145 increased, 99 reduced and 19 closed positions. Its largest new stake was AstraZeneca: 13,360 shares worth $2.53M. The largest sale was Amazon, an estimated $3.87M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- Natural Investments's largest Q2 2026 buy was AstraZeneca: 13,360 shares worth $2.53M.
- Natural Investments added most to AXS Change Finance ESG ETF in Q2 2026, an estimated $1.7M increase.
- Natural Investments's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.87M.
- Natural Investments fully exited Sony in Q2 2026, selling an estimated $1.71M.
- Natural Investments's ten largest holdings make up 36% of its $455M portfolio in Q2 2026.
- Natural Investments opened 32 new positions and closed 19 in Q2 2026.
- Natural Investments's portfolio value rose 12% quarter-over-quarter to $455M.
Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.